198 3-month ivacaftor (Kalydeco™) treatment resulted in weight gain, decreased resting energy expenditure and gut inflammation, and increased pulmonary function, muscle mass and strength, and growth status
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI